Dose-Volume Relationships for Acute Bowel Toxicity in Patients Treated With Pelvic Nodal Irradiation for Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 1, 2009, Pages 29-35

  Fiorino, Claudio ^a   Alongi, Filippo ^a,b   Perna, Lucia ^a   Broggi, Sara ^a   Cattaneo, Giovanni Mauro ^a   Cozzarini, Cesare ^a   Di Muzio, Nadia ^a   Fazio, Ferruccio ^a   Calandrino, Riccardo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

Author keywords

Dose volume effects; IMRT; Prostate cancer; TomoTherapy

Indexed keywords

BOWEL TOXICITY; DOSE-VOLUME; DOSE-VOLUME EFFECTS; DOSE-VOLUME HISTOGRAMS; HELICAL TOMOTHERAPY; IMRT; LOCALIZED PROSTATE CANCER; MULTI VARIATE ANALYSIS; PLANNING TARGET VOLUMES; PREDICTIVE VALUES; PROSTATE CANCER; PROSTATE CANCERS; STUDY GROUPS; TOMOTHERAPY; UNIVARIATE; UNIVARIATE ANALYSIS; WHOLE-PELVIS RADIOTHERAPY;

DECISION MAKING; FAULT TOLERANT COMPUTER SYSTEMS; IRRADIATION; MULTIVARIANT ANALYSIS; NATURAL LANGUAGE PROCESSING SYSTEMS; PATIENT MONITORING; PHYSICAL THERAPY; SURGERY;

TOXICITY;

ABDOMINAL SURGERY; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; GASTROINTESTINAL TOXICITY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PELVIS SURGERY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; TOMOTHERAPY; TREATMENT PLANNING;

ANALYSIS OF VARIANCE; HUMANS; INTESTINES; LYMPHATIC IRRADIATION; MALE; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SALVAGE THERAPY; STATISTICS, NONPARAMETRIC; TUMOR BURDEN;

EID: 68949131492     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.086     Document Type: Article

References (43)

1. Dirix P., Haustermans K., Junius S., et al. The role of whole pelvic radiotherapy in locally advanced prostate cancer. Radiother Oncol 79 (2006) 1-14
2. Roach M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
3. Roach M., DeSilvio M., Valicenti R., et al. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys 66 (2006) 647-653
4. Ashman J.B., Zelefsky M.J., Hunt M.S., et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 765-771
5. Cavey M.L., Bayouth J.E., Colman M., et al. IMRT to escalate the dose to the prostate while treating the pelvic nodes. Strahlenther Onkol 181 (2005) 431-441
6. Luxton G., Hancock S.L., and Boyer A.L. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 59 (2004) 267-284
7. Nutting C.M., Convery D.J., Cosgrove V.P., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 649-656
8. Price R.A.J., Hannoun-Levi J.M., Horwitz E., et al. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 583-592
9. Sanguineti G., Cavey M.L., Endres E.J., et al. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?. Strahlenther Onkol 182 (2006) 543-549
10. Sanguineti G., Cavey M.L., Endres E.J., et al. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?. Int J Radiat Oncol Biol Phys 64 (2006) 151-160
11. Vaarkamp J., Adams E.J., Warrington A.P., and Dearnaley D.P. A comparison of forward and inverse planned conformal, multi segment and intensity modulated radiotherapy for the treatment of prostate and pelvic nodes. Radiother Oncol 73 (2004) 65-72
12. Wang-Chesebro A., Xia P., Coleman J., et al. Intensity-modulated radiotherapy improves lymphnode coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 654-662
13. Liu Y.M., Shiau C.Y., Lee M.L., et al. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical sparing in prostate cancer. Int J Radiat Oncol Biol Phys 67 (2007) 1113-1123
14. Hong T.S., Tomè W.A., Jaradat H., et al. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Acta Oncol 45 (2006) 717-727
15. Adams E.J., Convery D.J., Cosgrove V.P., et al. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol 70 (2004) 1-10
16. Cozzarini C., Fiorino C., Di Muzio N., et al. Significant reduction of acute toxicity following pelvic irradiation with Helical TomoTherapy in patients with localized prostate cancer. Radiother Oncol 84 (2007) 164-170
17. Arcangeli S., Saracino B., Petrongari M.G., et al. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous. Radiother Oncol 84 (2007) 148-155
18. Muren L.P., Wasbo E., Helle S.I., et al. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: Planning procedures and early experiences. Int J Radiat Oncol Biol Phys 71 (2008) 1034-1041
19. Sanguineti G., Endres E.J., Parker B.C., et al. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer. Acta Oncol 47 (2008) 301-310
20. Letschert J.G., Lebesque J.V., Aleman B.M., et al. The volume effect in radiation-related late small bowel complications: Results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol 32 (1994) 116-123
21. Minsky B.D., Conti J.A., Huang Y., and Knopf K. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13 (1995) 1409-1416
22. Baglan K.L., Frazier R.C., Yan D., et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 176-183
23. Roeske J.C., Bonta D., Mell L.K., et al. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Int J Radiat Oncol Biol Phys 69 (2003) 201-207
24. Tho L.M., Glegg M., Paterson J., et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66 (2006) 505-513
25. Huang E.Y., Sung C.C., Ko S.F., et al. The different volume effects of small-bowel toxicity during pelvic irradiation between gynaecological patients with and without abdominal surgery: A prospective study with computed-tomography-based dosimetry. Int J Radiat Oncol Biol Phys 69 (2007) 732-739
26. Robertson J.M., Lockman D., Yan D., and Wallace M. Te dose-volume relationships of small bowel irradiation and acute Grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 70 (2008) 413-418
27. Martinez-Monge R., Fernandes P.S., et al. Cross-sectional nodal atlas: A tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology 211 (1999) 815-828
28. Mackie T.R., Kapatoes J., Ruchala K., et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 89-105
29. Mackie T.R., Holmes T., Swerdloff S., et al. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20 (1993) 1709-1719
30. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78 (2006) 276-282
31. Grigorov G., Kron T., Wong E., et al. Optimization of Helical Tomotherapy treatment plans for prostate cancer. Phys Med Biol 48 (2003) 1933-1943
32. Shepard D.M., Olivera G.H., Reckwerdt P.J., and Mackie T.R. Iterative approaches to dose optimization in tomotherapy. Phys Med Biol 45 (2000) 69-90
33. Fokdal L., Honore H., Hoyer M., and von der M. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 74 (2005) 203-210
34. Hysing L.B., Kvinnsland Y., Lord H., and Muren L.P. Planning organ at risk volume margins for organ motion of the intestine. Radiother Oncol 80 (2006) 349-354
35. Sanguineti G., Little M., Endres E.J., et al. Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer. Radiother Oncol 88 (2008) 95-101
36. Kvinnsland Y., and Muren L.P. The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer. Radiother Oncol 76 (2005) 43-47
37. Hysing L.B., Skorpen T.N., Alber M., et al. Influence of organ motion of conformal vs intensity-modulated pelvic radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 71 (2008) 1496-1503
38. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
39. Fiorino C., Fellin G., Rancati T., et al. Clinical and dosimetric predictors of late rectal syndrome after 3DCRT for localized prostate cancer: Preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 70 (2008) 1130-1137
40. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
41. Peeters S.T.H., Hoogeman M., Heemsbergen W.D., et al. Rectal bleeding, fecal incontinence and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 66 (2006) 11-19
42. Fonteyne V., De Neve W., Villeirs G., et al. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: The need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. Radiother Oncol 84 (2007) 156-163
43. Smit W.G., Pa H., van Putten W.L., et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 18 (1990) 23-29